|
|
|
11-50 employees
View all
|
|
Pharmaceuticals
|
|
77 Sleeper St, Boston, MA 02210, US
|
|
A discovery through early clinical phase pharmaceutical company, Ratio Therapeutics employs a suite of innovative technologies to develop best-in-class targeted radiotherapeutics for the treatment of cancer.
Ratio Therapeutics’ Trillium™ targeting scaffold combines pharmacokinetic modulation with best-in-class chelation technology to create proprietary small molecule targeting agents to attack a broad array of cancer targets. Our compounds accommodate imaging and therapeutic radioisotopes, ie "theranostics". The tunable nature of our platform combined with small-scale imaging trials in patients results in accelerated, de-risked compound selection.
|
Ratio Therapeutics Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}{last} | [email protected] |
75.00%
|
The widely used Ratio Therapeutics email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.
To contact Ratio Therapeutics customer service number in your country click here to find.
Jack Hoppin is the CEO of Ratio Therapeutics. To contact Jack Hoppin email at [email protected].
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.